Atlas Trials

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease

Clinical trial NCT03033108 · COMPLETED

Trial details

NCT number
NCT03033108
Sponsor
Kubota Vision Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stargardt DiseaseMacular Atrophy
Start date
2017-01-01
Primary completion
2017-11-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.